Here we identify dual, tissue-specific roles for the Hedgehog co-receptor BOC in both the promotion and antagonism of Hedgehog signaling during craniofacial development.
Introduction 17
Hedgehog (HH) signaling regulates the patterning and growth of nearly every tissue in the body 18 (Briscoe and Therond, 2013; McMahon et al., 2003) . Aberrant HH pathway activity results in severe birth 19 defects including Holoprosencephaly (HPE), a defect characterized by the failure of the division of the 20 embryonic forebrain into two cerebral hemispheres (Muenke and Beachy, 2000) . HPE is one of the most 21 common birth defects in humans, estimated to affect as many as 1 in 250 embryos (Hong and Krauss, 2018) . 22
The clinical manifestations of HPE are highly heterogeneous, consisting of a wide phenotypic spectrum of 23 defects (Schachter and Krauss, 2008) . Notably, 80% or more of HPE cases will display facial defects in 24 addition to forebrain malformations (Schachter and Krauss, 2008) . 25
Multiple mutations associated with developmental signaling pathways such as HH, have been 26 identified in human HPE patients (Roessler and Muenke, 2010) . Specifically, mutations in Sonic Hedgehog 27 (SHH) account for 6%-8% of sporadic HPE (Roessler et al., 2009 ). During craniofacial development Shh 28 regulates the establishment of forebrain identity, and patterns the face primordia (Schachter and Krauss, 29 2008) . Moreover, disruption of Shh in mice results in abnormal dorsoventral patterning in the neural tube, 30 defective axial skeleton formation and alobar HPE (Chiang et al., 1996) . 31 SHH ligands signal through the twelve-pass transmembrane receptor Patched (PTCH1), (Marigo et 32 al., 1996) . However, SHH also binds three co-receptors, growth arrest specific 1 (GAS1), CAM- Lum et al., 2003) . GAS1 is a vertebrate-specific, GPI-anchored protein with 38 structural resemblance to GDNF receptors (Cabrera et al., 2006) . In the absence of SHH ligand, PTCH1 39 inhibits the activity of the GPCR-like protein Smoothened (SMO). SHH ligand binding to PTCH1 and 40 GAS1, CDON or BOC releases SMO inhibition leading to a signal transduction cascade that results in 41 modulation of the GLI family of transcriptional effectors (Hui and Angers, 2011) . Together, GAS1, CDON Similar to Shh mutants, simultaneous genetic removal of Gas1, Cdon and Boc results in alobar HPE 46 (Allen et al., 2011) . Further, multiple mutations in these HH co-receptors have been identified in human 47 Gas1 -/and Cdon -/embryos display a spectrum of HPE phenotypes that range from proper telencephalic 114 vesicle (TV) division with normal MNP separation, to no TV division with no MNP separation ( Fig. 2A-D , 115 E-H; Fig. S2 ). Most of these mutants exhibit incomplete TV division (76% of Gas1 -/embryos, and 50% of 116 Cdon -/embryos), while a smaller portion (12% and 17%, respectively) of these mutants fails to divide the 117 TV ( Fig. 2M ). Gas1 -/and Cdon -/embryos predominantly show either incomplete MNP separation (47% of 118 Gas1 -/embryos, and 33% of Cdon -/embryos) or no MNP separation (29% and 42%, respectively; Fig. 2N) . 119
Notably, a minority of Gas1 and Cdon mutants have more mild phenotypes that are characterized by normal 120 TV division ( Fig. 2M) and either normal or reduced MNP separation (Fig. 2N) . In contrast, Boc -/embryos 121 do not manifest any gross craniofacial defects ( Fig. 2I-L) , with 100% of embryos displaying normal TV 122 division and normal MNP separation ( Fig. 2M-N) . Together, these data indicate that even on a congenic 123 C57BL/6J genetic background there remains a spectrum of HPE phenotypes observed in Gas1 and Cdon 124 mutants. Strikingly, and despite the broad expression of Boc in multiple HH-responsive cell types in the 125 developing forebrain (Fig. 1) , we do not observe any HPE phenotypes in Boc mutants maintained on a 126 C57BL/6J background. 127
To further characterize the spectrum of HPE phenotypes, we quantified the internasal distance in 128 E10.5 embryos. Consistent with our initial assessment, this quantitation revealed significant reductions in 129 the internasal distance in both Gas1 and Cdon mutant embryos ( Fig. 2O) . Surprisingly, this quantitation also 130 revealed an unexpected subtle, but significant increase in the internasal distance in Boc mutant embryos 131 compared to wildtype embryos (443µm in wildtype embryos and 496µm in Boc -/embryos; Fig. 2O ). These 132 data suggest potentially opposing roles for Gas1 and Cdon compared to Boc during mammalian craniofacial 133 development. One explanation for these counterintuitive results is that the increased internasal distance in 134
Boc embryos was due to an overall increase in embryo size. Therefore, we measured the crown-rump length 135 (CRL) in E10.5 wildtype and mutant embryos ( Fig. S3A -E). While Gas1 mutants are significantly smaller 136 than their wildtype littermates, both Cdon and Boc mutant embryos have similar CRL as wildtype embryos 137 ( Fig. S3F ). These data support the notion that the MNP widening observed in Boc mutants at E10.5 reflects 138 differences in the contribution of this HH co-receptor to craniofacial development. Interestingly, widening 139 or duplication of midfacial tissues is associated with increased levels of HH signaling (Brugmann et al., 140 2010; Hu and Helms, 1999) . 141
To determine if the variable craniofacial defects observed in these HH co-receptor mutant embryos 142 correlates with HH pathway activity, we performed in situ hybridization for Gli1, a general and direct 143 transcriptional target of HH signaling (Dai et al., 1999) . Gli1 is expressed in multiple craniofacial structures, 144
including the MNP, MXP and MP ( Fig. S4A ). Gas1 -/and Cdon -/embryos with less severe HPE phenotypes 145 maintain Gli1 expression in the MNP, but embryos with increasingly severe HPE phenotypes display a loss 146 of Gli1 expression in the MNP ( together, these data demonstrate that HPE severity in Gas1 and Cdon mutant embryos correlates with Gli1 149 loss in the MNP, and confirms that Boc mutants do not display any reduced HH pathway activity during 150 craniofacial development. 151
While previous studies suggested that combinatorial deletion of Gas1, Cdon, or Boc results in more 152 severe HPE phenotypes (Allen et al., 2011; Allen et al., 2007; Seppala et al., 2014; Zhang et al., 2011) , work 153 in zebrafish suggested a potential negative role for Boc in lower jaw development (Bergeron et al., 2011) . 154
Furthermore, a Boc missense variant associated with increased HH pathway activity has been recently 155 identified in human HPE patients (Hong et al., 2017) . The midface widening that we observed in Boc -/-156 embryos ( Fig. 2O ) is consistent with a role for Boc as a potential HH antagonist during craniofacial 157 development. To explore this possibility, we deleted Boc in combination with Gas1 deletion on a congenic 158 C57BL/6J background. 159
Analysis of E10.5 Gas1 -/-;Boc -/embryos revealed a spectrum of HPE phenotypes, as observed in 160
Gas1 -/embryos ( Fig. S4M-O) . Importantly, the HPE phenotypes observed in Gas1;Boc double mutants are 161 less severe than those observed in Gas1 single mutants (cf. Fig. 3B and 3D). Specifically, we observed an 162 increase in the percentage of Gas1;Boc double mutants with normal TV division compared to Gas1 single 163 mutants (31% vs. 12%, respectively; Fig. 3E ). Further, we found that 50% of Gas1;Boc double mutants 164 display MNP separation compared to 24% of Gas1 mutants ( Fig. 3F ). To investigate whether this rescue 165 was due to increased overall embryo size, we measured the CRL of Gas1 -/-;Boc -/embryos ( Fig. S5A -E). We 166 find that Gas1 -/-;Boc -/embryos tend to be smaller than Gas1 -/embryos ( Fig. 5F ); while not statistically 167 significant, these data rule out increased embryo size as an explanation for the rescue of the HPE 168 phenotypes. Overall, these data suggest that Boc deletion in a Gas1 mutant background partially rescues TV 169 and MNP separation in E10.5 embryos. 170
To determine if the phenotypes observed in Gas1;Boc mutants correlate with changes in HH 171 pathway activity, we performed in situ hybridization for the direct HH transcriptional target Gli1 in E10.5 172 wildtype, Gas1 -/-, Boc -/-, and Gas -/-;Boc -/embryos ( Fig 3G-J) . Gas1 -/-;Boc -/embryos that display increased 173 MNP separation also display increased Gli1 expression in the MNP (Fig 3J) , consistent with the notion that 174
Boc antagonizes HH pathway activity during craniofacial development. We also examined Gli1 expression 175 in the forelimb bud from these same embryos ( Fig. 3G '-J'). Notably, we detected decreased Gli1 expression 176 in Gas1;Boc mutants compared to wildtype and Gas1 mutant embryos (cf. Fig. 3G ', H', J'). Together these 177 data suggest that loss of Boc partially and selectively rescues HPE phenotypes observed in Gas1 mutant 178 embryos, through increased HH pathway activity. 179
To examine the consequences of Boc deletion on additional targets of the HH pathway, and to begin 180 to dissect possible tissue-specific contributions to craniofacial development, we investigated HH-dependent 181 neural patterning in both the developing forebrain and spinal cord ( Fig. 4 ). Specifically, we used whole 182 mount immunofluorescence to analyze the expression of NKX2.1, a direct HH transcriptional target in the 183 7 ventral telencephalon (Pabst et al., 2000) ( Fig. 4E -H,M). In E10.5 Gas1 -/embryos the expression domain of 184 NKX2.1 is significantly reduced (Fig. 4F ), while the NKX2.1+ domain in Boc -/embryos is unchanged 185 compared to wildtype embryos (cf. Fig. 4E ,G). Notably, compared to Gas1 -/embryos ( Fig. 4F ), Gas1 -/-;Boc -186 /embryos maintain a similar NKX2.1+ domain ( Fig. 4H ). Quantitation confirms that the NKX2.1+ area is 187 not significantly altered in Gas1 -/-;Boc -/embryos compared to Gas1 -/embryos ( Fig. 4M ). We also 188 confirmed that NKX2.1 is not significantly different in Boc -/embryos ( Fig. 4M ). Together, these data 189 suggest that, despite its broad expression in the forebrain neuroepithelium ( Fig. 1T ), Boc does not positively 190 contribute to HH-dependent patterning in this tissue. These data do raise the question of whether Boc can 191 regulate HH signaling in the developing telencephalon, or whether it may be playing an antagonistic role. 192
To address these possibilities, we used chicken in ovo telencephalon electroporations to assess Boc function 193 during HH-dependent neural patterning in the forebrain ( Quantitation of patterning in Boc -/embryos revealed a slight, but significant reduction in the NKX2.2 206 population ( Fig. 4K,N) . Strikingly, Gas1 -/-;Boc -/embryos have a very severe phenotype-OLIG2 expression 207 is completely absent (Fig. 4L) , and we observe a near complete absence of NKX2.2 expression ( Fig.4 L,N) . 208
In some sections from Gas1;Boc mutants we could detect a few NKX2.2+ cells ( Fig. 4L , inset). Overall, 209 these data are consistent with previous studies (Allen et al., 2011), and further demonstrates that Boc 210 selectively contributes to spinal cord, but not forebrain neural patterning. 211
Given that E10.5 Gas1 -/-;Boc -/mutants manifest a partial rescue of the craniofacial defects observed that the nasal bone in Gas1 -/-;Boc -/mutants is partially restored compared to Gas1 -/mutants where this 244 bone is smaller and fragmented ( Fig. 5N ', P'). As we observed at E10.5 (Fig. 2) , there is a spectrum of HPE 245 phenotypes in Gas1 mutants ( Fig. S7A-D) ; however, we consistently observe that the nasal bone of 246 Gas1;Boc mutants is not as severely affected as the Gas1 single mutants ( Fig. S7A '-D'). These data confirm 247 that Gas1 -/-;Boc -/embryos display a less severe phenotype in the nasal bone and in the nasal capsule than 248
To investigate the mechanisms that could explain the partial rescue observed in Gas1 -/-;Boc -/-250 embryos, we analyzed tissue-specific proliferation in the telencephalon of E10.5 wildtype and mutant 251 embryos. Specifically, we performed immunofluorescent detection of Phospho-Histone H3 (PH3) in slides 252 and co-stained with antibodies directed against E-CADHERIN (E-CAD) and PDGFRα to discriminate 253 9
between the surface ectoderm, forebrain neuroepithelium, and craniofacial mesenchyme ( Fig. 6A-E) . 254
Coronal sections of E10.5 Gas1 -/mutant embryos display reduced numbers of PH3+ cells across the surface 255 ectoderm, forebrain neuroepithelium, and craniofacial mesenchyme ( Fig. 6B , F-H). Similarly, Cdon -/-256 embryos exhibit a significant decrease in proliferation both the surface ectoderm and craniofacial 257 mesenchyme ( Fig. 6C , F-H). In contrast, Boc -/embryos do not display any apparent changes in the 258 proliferation in the surface ectoderm or in the neuroepithelium (Fig. 6D, F,G) . Further, Boc -/embryos 259 display a significant increase in mesenchymal proliferation compared to wildtype embryos (Fig. 6H ). These 260 results suggest that Boc negatively regulates proliferation specifically in craniofacial mesenchyme. 261
We also investigated tissue-specific proliferation in Gas1 -/-;Boc -/mutant embryos. Notably, the 262 levels of proliferation in the surface ectoderm and the mesenchyme are not significantly different when 263 compared to wildtype embryos (Fig. 6F,H) In contrast, proliferation is significantly decreased in the 264 forebrain neuroepithelium of Gas1;Boc mutants ( Fig. 6G) . Surprisingly, this effect on proliferation appears 265 to be quite selective, as there are no significant changes in proliferation in Boc mutants in either the neural 266 tube or the forelimb mesenchyme ( Fig. S8 ). Overall, these data demonstrate that Boc functions in a non-267 redundant manner to restrict proliferation in the craniofacial mesenchyme, while acting in concert with 268
Gas1 and Cdon to promote proliferation in the forebrain neuroepithelium. 269
270
Discussion 271
Here we investigated the individual and combined contributions of the HH co-receptors Gas1, Cdon 272
and Boc during HH-dependent craniofacial development. We found that Boc displays a significantly broader 273 expression pattern than Gas1 and Cdon in multiple craniofacial structures. Surprisingly, and distinct from 274
Gas1 and Cdon, loss of Boc alone does not result in any detectable reduction of HH pathway activity in 275 developing craniofacial structures. Instead, we find that genetic deletion of Boc results in facial widening 276 that is consistent with increased HH pathway activity (Brugmann et al., 2010; Hu and Helms, 1999) . 277
Further, analysis of Gas1;Boc double mutants revealed an amelioration of the craniofacial phenotype 278 observed in Gas1 single mutants, corresponding with increased HH pathway activity, and consistent with 279 the notion that loss of Boc can counterintuitively drive increased HH signaling. Notably, this improvement 280 is restricted to a subset of craniofacial structures, but persists throughout embryonic development. 281
Mechanistic analyses suggest that Boc achieves these tissue-specific effects through the selective restriction 282 of proliferation in the neural crest-derived mesenchyme. Taken together, these data demonstrate that Boc 283 regulates HH signaling in a tissue-specific manner, and suggests that, in certain tissues, BOC works in 284 opposition to other HH co-receptors to restrain HH pathway function. 285
Genetic background-dependent phenotypic differences in HH co-receptor mutants 286
Understanding the molecular mechanisms that underlie HPE is confounded by the significant 287 phenotypic variability observed in this disease, and the complex genetics that contribute to proper 288 craniofacial development. Our data indicate that, even when maintained on a congenic C57BL/6J 289 background, Gas1 and Cdon mutants display a range of HPE phenotypes. These phenotypes vary from 290 microforms of HPE to semilobar HPE, and their severity correlates with HH pathway activity as assessed by 291
Gli1 expression. The variability in the HPE phenotypes of our mutants could be explained due to multiple 292 genetic and non-genetic risk factors (Hong and Krauss, 2018) . In particular, the variable severity across the 293 phenotypes in our mutants could arise from stochastic changes in the establishment or response to the SHH 294 morphogen gradient in the neuroepithelium, neural crest-derived mesenchyme, and/or surface ectoderm. In 295 early craniofacial structures Shh is expressed sequentially, initiating in the prechordal plate, followed by the 296 diencephalon and telencephalon, subsequently in the surface ectoderm of the frontonasal prominence, and 297 expression sequence of Shh, which is required to properly pattern the craniofacial structures (Krauss, 2007) , 300 combined with the differential expression of multiple HH receptors could generate an inherent variability 301 that affects the severity of the HPE phenotypes. 302
The lack of craniofacial defects in Boc mutants maintained on different genetic mixed backgrounds 303 studies where Boc deletion in a Gas1 or Cdon null background enhances HPE severity and decreases the 306 levels of HH pathway targets (Seppala et al., 2014; Zhang et al., 2011) . However, our data indicate that Boc 307 mutants on a C57BL/6J background exhibit internasal distance widening in E10.5 embryos. These data 308 suggest an antagonistic role for Boc in HH signaling and comports with a previous description of Boc as a 309 potential HH pathway antagonist in the zebrafish lower jaw (Bergeron et al., 2011) . While we do not 310 observe any mandible phenotypes in Boc -/embryos, species-specific differences in craniofacial 311 development between mouse and fish likely limit our ability to draw a direct connection. Alternatively, our 312 analysis of Boc in the developing mandible may not be comprehensive enough to reveal this function. 
Tissue-specific functions of BOC in HH signal transduction 331
Analysis of HH transcriptional targets revealed that Boc deletion results in differential changes in 332 HH-dependent gene expression in a tissue-specific fashion (Fig. 7A ). Specifically, our data suggest that 333 BOC promotes the expression of the direct HH transcriptional target, NKX2.2, in the spinal cord 334 neuroepithelium, but does not contribute to expression of NKX2.1 in the telencephalon neuroepithelium. 335
These data suggest that BOC differentially regulates HH-dependent neural patterning at distinct axial levels. 336
Further, BOC promotes Gli1 expression in the limb bud mesenchyme, but antagonizes Gli1 expression in 337 the forebrain mesenchyme. Notably, Boc appears to selectively impact HH-dependent patterning, but not 338 proliferation in the developing limb bud; conversely, Boc selectively inhibits proliferation in the neural 339 crest-derived mesenchyme of the craniofacial structures ( Fig 7A) . This is consistent with previous work by 340 12
(Xavier et al., 2016b) suggesting that Boc contributes to mesenchymal proliferation in the palatal shelf. 341
Taken together, these data argue that BOC regulates patterning and proliferation in a tissue-specific manner 342 and raises the possibility that BOC performs multiple, and in some cases, opposing roles in HH signal 343 transduction. 344
Boc as a multi-functional regulator of HH signaling 345
Based on our data, and the work of others, we propose a model whereby BOC acts as a multi-346 functional receptor to contribute to vertebrate embryogenesis (Fig. 7B) . Specifically, we propose that BOC 347 can act to: 1) promote HH signaling through interactions with HH ligands and the canonical receptor Subsequently, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4 + 0.02% NP-40 for 390 permeabilization. B-Galactosidase activity was detected with X-Gal staining solution (5mM K 3 Fe(CN) 6 , 391 5mM K 4 Fe(CN) 6 , 2mM MgCl 2 , 0.01% Na deoxycholate, 0.02% NP-40, 1mg/mL X-gal). The signal was 392 developed from 25 minutes to 24 hours at 37° C depending on the lacZ allele. After staining, the embryos 393 were washed 3 x 5 minutes with 1X PBS, pH 7.4 at 4°C, and post-fixed in 4% paraformaldehyde for 20 394 minutes at room temperature, followed by 3 x 5 minute washes in 1X PBS, pH 7.4. Finally, embryos were 395 stored and photographed in 1X PBS, pH 7.4 + 50% glycerol. X-gal staining of sections (20µm) was 396 performed as described above for whole mount embryos. After staining, sections were washed 3 x 5 minutes 397 with 1X PBS, pH 7.4, counterstained with nuclear fast red for 5 minutes and dehydrated in an ethanol series 398 (70% ethanol, 95% ethanol, 100% ethanol and 100% Xylenes) followed by application of coverslips with 399 permount mounting media. 400 401
Alkaline Phosphatase Staining 402
Subsequently, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4. To deactivate endogenous 405 alkaline phosphatases, embryos were incubated in 1X PBS, pH 7.4 at 70°C for 30 minutes. Then the 406 embryos were rinsed with 1X PBS, pH 7.4 and washed for 10 minutes in alkaline phosphatase buffer 407 (100mM NaCl, 100mM Tris-HCl pH9.5, 50mM MgCl 2 , 1% Tween-20) at room temperature. Embryos were 408 stained with BM purple from 2 to 3 hours at 37°C depending on the embryonic stage. After staining, the 409 embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4 at 4°C, and post-fixed in 4% paraformaldehyde 410 for 20 minutes at room temperature, followed by 3 x 5 minute washes with 1X PBS, pH 7.4. Finally, 411 embryos were stored and photographed in 1X PBS, pH 7.4 + 50% glycerol. Alkaline phosphatase staining 412 of sections (20µm) was performed as described above for whole mount embryos. After staining, sections 413 were washed 3 x 5 minutes with 1X PBS, pH7.4, counterstained with nuclear fast red for 5 minutes and 414 dehydrated in an ethanol series (70% ethanol, 95% ethanol, 100% ethanol and 100% xylenes for five 415 minutes each) followed by application of coverslips with permount mounting media. 416 417
Whole-Mount Digoxigenin in situ Hybridization 418
Whole-mount digoxigenin in situ hybridization was performed as previously described in (Allen et al., 419 2011; Wilkinson, 1992) . In brief, embryos were dissected in 1X PBS, pH 7.4 and fixed in 4% 420 paraformaldehyde overnight on a rocking platform. After fixation, embryos were dehydrated in a 421 methanol/PBST (1X PBS, pH 7.4 + 0.1 % Tween) series (25% methanol, 50 %methanol, 75% methanol) 422 and stored in 100% methanol at -20°C until the experiment was performed for up to 6 months. Embryos 423 were digested with 10µg/mL proteinase K at RT for 2 minutes. Hybridization was performed with the 424 indicated digoxigenin probe with a concentration of 1ng/µL for 16-19 hours at 70°C. The embryos were 425 incubated in alkaline phosphatase-conjugated anti-DIG antibody at a dilution of 1:4,000. AP-anti-DIG was 426 detected with BM purple, and signal was developed for 3.5 hours at room temperature. Embryos were 427 cleared in 50% glycerol in 1XPBST and were photographed using a Nikon SMZ1500 microscope. provided in supplementary table 2. Secondary antibodies were diluted in blocking solution and incubated for 438 1 hour at room temperature, followed by 3 x 5 minute washes with 1X PBS, pH 7.4. All Alexa Fluor Dyes 439 secondary antibodies were used at a 1:500 dilution. Nuclei were labeled with DAPI for 10 minutes at room 440 temperature and slides were mounted with coverslips using Immu-mount aqueous mounting medium. 441
Sections were visualized on a Leica upright SP5X confocal microscope. 442 443
Whole-Mount Immunofluorescence 444
Embryos were dissected in 1X PBS, pH 7.4, fixed with 4% paraformaldehyde for 2 hours at 4°C, and 445
washed 2 x 10 minutes washes with PBTX (1X PBS + 0.1% Triton X-100). Subsequently, embryos were 446 blocked for 1 hour in PBTX + 10% goat serum. Primary antibodies were diluted in PBTX + 10% goat 447 serum and incubated overnight at 4 °C on a rocking platform. A list of all the primary antibodies used in this 448 study is provided in the supplementary table 2. The next day the embryos were rinsed 2 x 5 minutes with 449 PBTX, followed by 3 x 1 hour washes with PBTX on a rocking platform at 4°C. After the washes, embryos 450 were incubated overnight with secondary antibodies diluted in PBTX+ 10% serum. All Alexa Fluor Dyes 451 secondary antibodies were used at a 1:500 dilution. Next, embryos were washed as described for the 452 primary antibody above, and cleared with Clear T2 (25% Formamide/10%PEG for one hour; 50% 453 E18.5 embryos were skinned and eviscerated. Subsequently, embryos were fixed overnight in 100% 459 ethanol, and maintained in 70% ethanol until ready to scan. The scans were performed using embryos 460 covered with a 1X PBS, pH 7.4-soaked kim wipe and scanned over the entire length of the skull using the 461 µCT100 system (Scanco Medical, Bassersdorf, Switzerland). Scan settings were as follows: 12 µm voxel 462 size, 55 kVp, 109 µA, 0.5 mm AL filter, and 500 ms integration time. Micro CT scans were analyzed with 463 the Amira software (Thermo Fisher Scientific). The Micro CT scans were uploaded as DICOM files into the 464 software and the three-dimensional reconstructions were generated using the isosurface feature. The 465 individual bones were manually segmented using the extract surface and buffer tools of Amira (Ho et al., 466 2015) . Finally, the individual bones were color coded. 467
468

Skeletal Preparation 469
Skeletons were prepared as previously described before in (Allen et al., 2011). E18.5 embryos were skinned 470 and eviscerated. Subsequently, embryos were fixed in 100% ethanol, followed by 100% acetone for 24 471 hours respectively at room temperature. Cartilage and bone were stained with alcian blue/alizarin red 472 16
staining solution (5% alcian blue, 5% alizarin red, 5% glacial acetic acid and 70% ethanol) for 4 days at 473 room temperature. The remaining tissue was digested with several washes of 1% potassium hydroxide. The 474 skeletons were cleared by 24 hour washes of a gradient of glycerol (20%, 50%, and 80%) in 1% potassium 475 hydroxide, and photographed in 80% glycerol. 476
477
In ovo chicken electroporations 478
Chicken electroporations were performed as previously described in (Allen et al., 2011; Tenzen et al., 479 2006) . The indicated construct (pCIG plasmid -1 µg/µl in 1X PBS, pH7.4, with 50ng/µl fast green) was 480 injected into the forebrain cavity of HH stage 11 chicken embryos. L-shaped electrodes were made with 481 platinum wire, 8mm long (3mm were bent to form the L shape) and spaced 6mm apart. Electrodes (L-482 shaped part) were placed in front of the forebrain of the embryo (pulsed five times at 25 V for 50 ms with a 483 BTX electroporator). The electroporated embryos were screened for GFP expression after 48 hours at HH 484 stage 21-22 and processed for immunofluorescence. 485
486
Quantitation and statistical analysis 487
All the data are represented as mean ± standard deviation. All statistical analyses were performed using 488
GraphPad statistic calculator (GraphPad Software, La Jolla California USA, www.graphpad.com). Frontal pictures of E10.5 mouse embryos were photographed with a Nikon SMZ1500 microscope. Blind 497 classification of the telencephalic division and media nasal process separation, was performed by a blinded 498 evaluator according the categories showed in (Fig S2A-F) . 499 500
Internasal distance and crown-rump length quantitation 501
Pictures of the nasal processes and whole E10.5 embryos were taken in 1X PBS, pH7.4 with a Nikon 502 SMZ1500 microscope. Internasal distance was defined as the distance between the edges of the medial nasal 503 process. Crown rump length was defined as top of the crown of the midbrain, bisecting the forelimb bud to 504 the curvature at the bottom c-shaped part of the embryo. Blind quantitation of the intranasal distance and 505 crown-rump length was performed manually by a single evaluator using the scale bar tool of the NIS-506
Elements software (Nikon) annotations and measurements feature. 507
Immunofluorescence quantitation 508
To quantify immunofluorescence images, we examined a minimum of 3 embryos per genotype and 2 509 sections from each embryo. 510 511 NKX2.1 quantitation: Side view pictures of whole mount immunofluorescent wildtype and mutant embryos 512 were taken in Clear T2 with a Nikon SMZ1500 microscope. The NKX2.1 area of expression was quantified 513 using the area measure plugin of ImageJ (Schneider et al., 2012) . Each image was thresholded automatically 514 by ImageJ before the area of expression was quantified. 515 516 NKX2.2 quantitation: Pictures of transverse sections of wildtype and mutant neural tubes stained with 517 antibodies directed against NKX2.2 were merged with their respective DAPI images. NKX2.2 positive cells 518 were quantified with the point tool of ImageJ (Schneider et al., 2012) . 519 520 Phospho-histone H3 quantitation: All phospho-histone H3 quantitation was performed with the point tool 521 feature of ImageJ (Schneider et al., 2012) . In the forebrain, the phospho-histone H3 positive cells were 522 quantified in different tissue compartments. The phospho-histone H3 images were merged with markers 523 specific to each tissue: E-CADHERIN (surface ectoderm), and PDGFRα (mesenchyme). The 524 neuroepithelium was identified morphologically. The dorsal telencephalic midline was excluded from this 525 analysis. For the neural tube quantitation, the phospho-histone H3 cells were quantified in the ventral limit 526 of expression of the NKX6.1 neural progenitors. Finally, in the forelimb bud, the phospho-histone H3 527 positive cells were quantified specifically in a selected area of equal size in wildtype and mutant embryos. 528
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